Lee John Sang 4
4 · PhaseBio Pharmaceuticals Inc · Filed Mar 1, 2019
Insider Transaction Report
Form 4
Lee John Sang
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2019-02-27+100,000→ 100,000 totalExercise: $3.15Exp: 2029-02-27→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest in equal monthly installments over 48 months from February 27, 2019, subject to the reporting person's continued service through each such date.